scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.CHROMA.2007.06.063 |
P698 | PubMed publication ID | 17640657 |
P2093 | author name string | Mei Han | |
Boxu Yan | |||
Susan Elliott | |||
John Valliere-Douglass | |||
Alain Balland | |||
Danielle Pace | |||
Lowell Brady | |||
Sean Steen | |||
Weichun Wang | |||
Yihong Han | |||
Zac Yates | |||
Dean Pettit | |||
P433 | issue | 1-2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 153-161 | |
P577 | publication date | 2007-07-05 | |
P1433 | published in | Journal of Chromatography | Q902558 |
P1476 | title | Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry. | |
P478 | volume | 1164 |
Q50860057 | A High-Throughput Bioluminescent Assay to Monitor the Deamidation of Asparagine and Isomerization of Aspartate Residues in Therapeutic Proteins and Antibodies. |
Q34223967 | A new tool for monoclonal antibody analysis: application of IdeS proteolysis in IgG domain-specific characterization |
Q36588710 | A novel approach for the simultaneous quantification of a therapeutic monoclonal antibody in serum produced from two distinct host cell lines |
Q39324555 | Capillary electrophoresis-mass spectrometry methods for tryptic peptide mapping of therapeutic antibodies |
Q38155231 | Characterization of immunoglobulin by mass spectrometry with applications for the clinical laboratory |
Q35624029 | Characterization of the basic charge variants of a human IgG1: effect of copper concentration in cell culture media |
Q94503762 | Computational Studies on the Mechanisms of Nonenzymatic Intramolecular Cyclization of the Glutamine Residues Located at N-Termini Catalyzed by Inorganic Phosphate Species |
Q38665164 | Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates. |
Q41955520 | Desulfurization of cysteine-containing peptides resulting from sample preparation for protein characterization by mass spectrometry |
Q37364361 | Developability studies before initiation of process development: improving manufacturability of monoclonal antibodies |
Q30398538 | FTIR markers of methionine oxidation for early detection of oxidized protein therapeutics |
Q37467563 | Human IgG1 hinge fragmentation as the result of H2O2-mediated radical cleavage |
Q88673235 | Kinetics and Characterization of Non-enzymatic Fragmentation of Monoclonal Antibody Therapeutics |
Q44517032 | Mass spectrometric distinction of in-source and in-solution pyroglutamate and succinimide in proteins: a case study on rhG-CSF. |
Q51791478 | Molecular mass analysis of antibodies by on-line SEC-MS. |
Q28821982 | Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodies |
Q30278544 | Pepsin-Containing Membranes for Controlled Monoclonal Antibody Digestion Prior to Mass Spectrometry Analysis |
Q38246996 | Post-translational structural modifications of immunoglobulin G and their effect on biological activity |
Q37122550 | RPLC of intact proteins using sub-0.5 μm particles and commercial instrumentation |
Q42929516 | Rapid and refined separation of human IgG2 disulfide isomers using superficially porous particles |
Q37689616 | Stability of protein pharmaceuticals: an update |
Q40115327 | The Effect of N-Terminal Cyclization on the Function of the HIV Entry Inhibitor 5P12-RANTES. |
Q42875883 | The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: down-regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant-based expression platforms |
Q38668408 | The use of proteases complementary to trypsin to probe isoforms and modifications. |
Search more.